Ledger.Open graph →
SEC Form D · filed September 13, 2018

Petra Pharma Corp

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Matthew R. Gottesdiener · Newton, MAPromoterRobert O. Tatum, Jr · Hattiesburg, MSExec · PromoterClifford M. Weiner · Dallas, TXDirector · PromoterLandel A. Hobbs · EDEN PRAIRIE, MNExec · DirectorIsrael E. Sendrovic · Fort Lee, NJDirectorTimothy A. Peterman · EDEN PRAIRIE, MNExecMichael A. Friedman · EDEN PRAIRIE, MNExecLawrence R. Gottesdiener · Newton, MADirectorKharen V. Musaelian · New York, NYDirectorSuzanne D. Abair · Newton, MADirector · PromoterKerwin Brandt · CHICAGO, ILDirectorSam Yagan · CHICAGO, ILPromoterTrent Dawson · KIRKLAND, WAExec · PromoterErik Anderson · KIRKLAND, WADirectorPatty Swenson · Mammoth Lakes, CADirector · PromoterDavid P. Bordo · McMurray, PADirectorAndrew V. Sheehan · San Mateo, CAPromoterD. L. King · San Mateo, CADirectorDrew E. Parker · Fort Lee, NJDirectorBrent R. Knudsen · Los Gatos, CAExec · DirectorGreg Dillmann · Naperville, ILExecRobert J. Bishop · Palm Beach, FLExecAxonic Structured Opportunities Fund GP LLC · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗